Home Page > PRIMARY CELL > GFP or RFP Labeled Cells > Human Cells > Non-Endothelial Cells >  Human VEGFR2 shRNA Stable Transfected GFP-HUVECs

Human VEGFR2 shRNA Stable Transfected GFP-HUVECs

Size Price Quantity
1.0 Vial $900.00
Name of Products Human VEGFR2-shRNA and GFP transfected Human Umbilical Vein Endothelial Cells (HUVECs-shRNAVR2GFP
Catalogue NumbercAP-0002siRNAVR2GFP
Product FormatFrozen Vial
Cell Number>5x10[5] cells/vial
HUVECs (cAP-0001) were infected with Lentiviral particles expressing human VEGFR2 specific shRNAs and GFP @ passage 1. Puromycin resistant HUVECs-shRNAVR2-GFP cells were selected and shipped in frozen vials (cells are provided @ passage 3). Endothelial Growth Medium (cAP-02) is recommended for cell culture and these cells have a minimum of 18 population doubling levels when cultured following the protocols described below).
1.Cytoplasmic VWF/Factor VIII >95% positive by immunofluorescence
2.Cytoplasmic uptake of Di-I-Ac-LDL >95% positive by immunofluorescence
3.Cytoplasmic PECAM1 >95% positive by immunofluorescence
4.HUVECs are negative for HIV-1, HBV, HCV, and mycoplasma
Cells are offered for Research Use Only.
Frozen Vials in Dry Ice package.
When you receive the dry ice package with cells in frozen vials, transfer the frozen vials of cells into a -80C freezer for short period storage or a liquid nitrogen tank for long- term storage.
A)Pre-coating of T25 flasks- Add 2ml each Quick Coating Solution (cAP-01) into a T25 flask to cover the whole surface of the flask, 5 mins later, dispose the excessive coating solution by aspiration and the flask is ready to be used (although solution containing other extracellular matrix, i.e. gelatin, collagen, and fibronectin, can be used, make sure to optimize the conditions in advance).
B)Thaw the frozen cell vial in a 37C water bath first, and then transfer the cells into the pre-coated T25 flask with 10ml of cAP-02 medium, cells usually become confluent overnight and ready to be passaged.
C)To passage the cells, rinse the cells in a T25 flask with 5ml HBSS (RT) twice; then add 2ml Trypsin/EDTA (RT) (cAP-23) into one T25 flask; gently dispose the excessive Trypsin/EDTA solution within 20 seconds by aspiration.
D)Leave the T25 flask with the cells at RT or 37C for 1 min (most cells usually will detach from the surface within 1-2 mins; or monitor the cells under a microscope until most of cells become rounded up, and then gently tap the flask against the bench surface, and the cells will move on the surface of the flask when monitoring under microscope.
E)Add 5ml Trypsin Neutralization Buffer and spin down the cells with 800g centrifugation for 5 mins.
G)Re-suspend the cell pellet with 10 or 15ml cAP-2 medium and transfer 5 ml each into 2 or 3 pre-coated T25 flasks (for 1/2 to 1/3 subculture ratio).
H)Change medium every 2 or 3days and the cells usually become confluent within 7 days (when split at a 1/3 ratio).
I)To prepare quiescent cells, when cells are nearly confluent, replace cAP-02 with Endothelial Basal Medium (EBM, cAP-03) containing 0.5%FBS for about 8-12hrs before your experiments.
Quick Coating SolutioncAP-01
Endothelial Growth MediumcAP-02
Endothelial Basal MediumcAP-03
HBSS w/o Ca2+, Mg2+cAP-11
Cell Freezing Solution (FBS)cAP-22
Cell Freezing Solution (Non-FBS)cAP-22B
Trypsin/EDTA SolutioncAP-23
Trypsin Neutralization SolutioncAP-28
ITS (100x)cAP-26
L-Glutamine-MAXIMUM (100x) cAP-27
Human Plasma Fibronectin SolutioncAP-42
Handling human tissue derived products is potentially bio-hazardous, despite tested negative for HIV, HBV and HCV DNA; nonetheless, proper precautions must be taken to avoid inadvertent exposure.